Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

43 44 Next >

Is Dexcom a Good Stock to Buy Now? ↗

May 02, 2023

A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it.

Via The Motley Fool

1 Stock-Split Stock That's a Surefire May Buy and 1 to Avoid ↗

May 02, 2023

A half-dozen, high-profile companies split their stock last year. One stands out as an exceptional value in May, while another is seeing its competitive advantages erode.

Via The Motley Fool

Elliott Wave Technical Analysis: DexCom Inc, Monday, May 1 ↗

May 01, 2023

DexCom Inc.broke through confirmation by breaking the green line and we are pulling back as expected. Looking for further upside into wave 3.

Via Talk Markets

Amazon Leads 5 S&P 500 Stocks Near Buy Points After Earnings ↗

April 29, 2023

Given recent earnings blowups, stocks that have already reported are worth watching.

Via Investor's Business Daily

DexCom (DXCM) Q1 2023 Earnings Call Transcript ↗

April 28, 2023

DXCM earnings call for the period ending March 31, 2023.

Via The Motley Fool

Check Out What Whales Are Doing With DXCM ↗

April 28, 2023

Via Benzinga

Top 2% Stock Dexcom Easily Beats First-Quarter Expectations, Boosts Outlook ↗

April 27, 2023

Dexcom is benefitting from the shift to continuous glucose monitors in diabetes management.

Via Investor's Business Daily

2 Growth Stocks That Could Double in 5 Years ↗

April 27, 2023

Both of these companies did more than that in the past five years.

Via The Motley Fool

P/E Ratio Insights for DexCom ↗

April 25, 2023

Via Benzinga

Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review ↗

April 28, 2023

Microsoft, Meta, Cloudflare and Crocs were among the many big movers.

Via Investor's Business Daily

Roblox And 3 Other Stocks Insiders Are Selling ↗

April 28, 2023

The Nasdaq Composite closed sharply higher on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Mastercard To Rally Over 18%? Here Are 10 Other Analyst Forecasts For Friday ↗

April 28, 2023

Wells Fargo raised the price target for Molina Healthcare, Inc. (NYSE: MOH) from $282 to $290. Wells Fargo analyst Stephen Baxter maintained an Underweight rating. Molina Healthcare shares gained 7.8%...

Via Benzinga

Elliott Wave Technical Analysis: DexCom Inc ↗

April 21, 2023

Looking for further upside into wave (C) as we have broken through the confirmation level (green line).

Via Talk Markets

$100 Invested In DexCom 5 Years Ago Would Be Worth This Much Today ↗

April 17, 2023

Via Benzinga

Where DexCom Stands With Analysts ↗

April 17, 2023

Via Benzinga

What To Know About Raymond James's Upgrade of DexCom ↗

April 17, 2023

Via Benzinga

DexCom Q1 Earnings Beat Sets Stage For Upcoming Catalysts During 2023, Analyst Says ↗

April 28, 2023

DexCom Inc (NASDAQ: DXCM) raised its 2023 financial guidance following strong

Via Benzinga

Dexcom Reports First Quarter 2023 Financial Results

April 27, 2023

From DexCom, Inc.

Via Business Wire

Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB

April 27, 2023

From Dexcom, Inc.

Via Business Wire

“Sell In May Effect”: Uncovering Investment Opportunities During Seasonal Weakness ↗

April 26, 2023

Despite the seasonal weakness that is often associated with the summer months, there are still market opportunities waiting to be uncovered.

Via Talk Markets

The Medicare Decision That Propelled Dexcom Stock Closer To A Breakout ↗

April 17, 2023

Now, 1.5 million more Americans will have access to CGMs, Dexcom said.

Via Investor's Business Daily

2 Monster Stocks to Buy Without Any Hesitation ↗

April 25, 2023

These stocks have grown revenue, earnings and share price over the past five years.

Via The Motley Fool

This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health ↗

April 25, 2023

The need for noninvasive healthcare technology that allows people to take ownership and gather more insight into their health became acute when COVID revealed the fragility of the hospital system.

Via Benzinga

3 Medtech Companies with Higher Future Share Prices

April 24, 2023

The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond.

Via MarketBeat

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review ↗

April 21, 2023

The major indexes saw modest declines, holding in a range.

Via Investor's Business Daily

Diversified Abbott Laboratories Could Reverse And Move Higher

April 19, 2023

Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline.

Via MarketBeat

Physician Checks And Latest Script Data Support DexCom Growth Opportunity: Bullish Analyst Upgrades Stock ↗

April 17, 2023

Via Benzinga

Visa To Rally 15%? Here Are 10 Other Analyst Forecasts For Monday ↗

April 17, 2023

Raymond James boosted the price target for DexCom, Inc. (NASDAQ: DXCM) from $127 to $138. Raymond James analyst Jayson Bedford upgraded the stock from Outperform to Strong Buy. DexCom shares rose 1.8%...

Via Benzinga

Healthcare Innovation Drives Medical Device Makers To New Highs

April 17, 2023

Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.

Via MarketBeat

Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗

April 17, 2023

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today